What Happened?
Cambridge , MA-based Proclara Biosciences Appointed Franz Hefti as President and Interim Chief Executive Officer
About the Company
Proclara is pioneering a new approach to treating neurodegenerative diseases. By developing novel therapies that recognize and target multiple misfolded proteins, we aim to make a transformative impact on the lives of patients affected by Alzheimer`s, Parkinson`s, and other diseases caused by protein misfolding. Our approach is shaped by an experienced team with deep drug development experience, and productive collaborations with world-class advisors and partners.
About the Person
Franz Hefti is President and Interim Chief Executive Officer at Proclara Biosciences. Previously, Franz held various senior HR leadership roles in the industry.
Info Source
News
Short Profile